🔎 Trials Near Me

Domov › Rak endometrija › Texas › Houston

Klinične študije za Rak endometrija v Houston, TX

68 študij za Rak endometrija išče udeležence na lokacijah v Houston in okolici (v razdalji približno 30 milj). Odprite študijo, da vidite, kdo lahko sodeluje in kako kontaktirati ekipo.

Uradno besedilo študije (angleško)

Iščete udeležence za študijo? Predstavite jo na vrhu te strani — $99 za 30 dni →

Targeted Therapy Directed by Genetic Testing in Treating Patients With Locally Advanced or Advanced Solid Tumors, The ComboMATCH Screening Trial

Vključevanje udeležencevFaza 2
  • Lyndon Baines Johnson General Hospital, Houston
  • UT MD Anderson Cancer Center, Houston
Vse starosti · Vsi spoli · Posodobljeno 2. okt. 2026 · NCT05564377

The Evaluation of PC14586 in Patients With Advanced Solid Tumors Harboring a TP53 Y220C Mutation (PYNNACLE)

Vključevanje udeležencevFaza 1/2
  • The University of Texas MD Anderson Cancer Center, Houston
Starost 12 in več · Vsi spoli · Posodobljeno 2. okt. 2026 · NCT04585750

A Phase 1 Study of PLN-101095 in Adults With Advanced or Metastatic Solid Tumors

Vključevanje udeležencevFaza 1
  • University of Texas MD Anderson Cancer Center, Houston
  • NEXT Houston, Houston
Starost 18 in več · Vsi spoli · Posodobljeno 2. okt. 2026 · NCT06270706

A Study to Learn More About How Well Treatment With Sevabertinib (BAY 2927088) Tablets Works and How Safe it is in Participants Who Have a Solid Tumor With Mutations of the Human Epidermal Growth Factor Receptor 2 (HER2)

Vključevanje udeležencevFaza 2
  • The University of Texas MD Anderson Cancer Center - Texas Medical Center, Houston
Starost 18 in več · Vsi spoli · Posodobljeno 2. okt. 2026 · NCT06760819

A Study of HER3-DXd in Subjects With Locally Advanced or Metastatic Solid Tumors

Vključevanje udeležencevFaza 2
  • The University of Texas MD Anderson Cancer Center, Houston
Starost 18 in več · Vsi spoli · Posodobljeno 1. okt. 2026 · NCT06172478

177Lu-BetaBart in Patients With Relapsed/Refractory, Locally Advanced Inoperable, or Metastatic Solid Tumors

Vključevanje udeležencevFaza 1/2
  • MD Anderson Cancer Center, Houston
Starost 18 in več · Vsi spoli · Posodobljeno 1. okt. 2026 · NCT07189871

Leveraging Methylated DNA Markers (MDMs) in the Detection of Endometrial Cancer, Ovarian Cancer, and Cervical Cancer

Vključevanje udeležencevOpazovalna študija
  • Total Women's Care of the Heights, Houston
Starost 18 in več · Ženske · Posodobljeno 29. sep. 2026 · NCT05051722

Phase 1 Study to Investigate TCRTs KRAS Mutation in Unresectable, Advanced, and/or Metastatic Solid Tumors

Vključevanje udeležencevFaza 1
  • Research Site, Houston
Starost 18 in več · Vsi spoli · Posodobljeno 25. sep. 2026 · NCT06218914

Study of REGN4018 (Ubamatamab) Administered Alone or in Combination With Cemiplimab in Adult Patients With Recurrent Ovarian Cancer or Other Recurrent Mucin-16 Expressing (MUC16+) Cancers

Vključevanje udeležencevFaza 1/2
  • The University of Texas MD Anderson Cancer Center, Houston
Starost 18 in več · Ženske · Posodobljeno 25. sep. 2026 · NCT03564340

Adjuvant Therapy in POLE-Mutated and p53-Wildtype/NSMP Early Stage Endometrial Cancer RAINBO BLUE & TAPER

Vključevanje udeležencevFaza 2
  • M.D. Anderson Cancer Center, Houston
Starost 18 in več · Ženske · Posodobljeno 24. sep. 2026 · NCT05640999

Study of Dato-DXd as Monotherapy and in Combination With Anti-cancer Agents in Patients With Advanced Solid Tumours (TROPION-PanTumor03)

Vključevanje udeležencevFaza 2
  • Research Site, Houston
Starost 18–130 · Vsi spoli · Posodobljeno 23. sep. 2026 · NCT05489211

Study of Elironrasib and Daraxonrasib as Monotherapies and Combination Therapy in Participants With Advanced KRAS G12C Mutant Solid Tumors

Vključevanje udeležencevFaza 1/2
  • MD Anderson, Houston
Starost 18 in več · Vsi spoli · Posodobljeno 22. sep. 2026 · NCT06128551

A Study of LY4257496 in Participants With Cancer (OMNIRAY)

Vključevanje udeležencevFaza 1
  • MD Anderson Cancer Center, Houston
Starost 18 in več · Vsi spoli · Posodobljeno 22. sep. 2026 · NCT07114601

EIK1005-002: A Clinical Research Study Evaluating EIK1005, a Werner Helicase Inhibitor, as Monotherapy and in Combination With Pembrolizumab in Participants With Advanced Solid Tumors Including Microsatellite Instability High (MSI-H) Tumors

Vključevanje udeležencevFaza 1/2
  • University of Texas MD Anderson Cancer Center, Houston
Starost 18 in več · Vsi spoli · Posodobljeno 22. sep. 2026 · NCT07262619

Evaluate BL-B01D1 in Patients With Metastatic or Unresectable Non-Small Cell Lung Cancer (NSCLC) and Other Solid Tumors

Vključevanje udeležencevFaza 1
  • Oncology Consultants, P.A., Houston
  • University of Texas M.D. Anderson Cancer Center, Houston
Starost 18 in več · Vsi spoli · Posodobljeno 21. sep. 2026 · NCT05983432

A Study to Compare Sacituzumab Tirumotecan (MK-2870) in Combination With Pembrolizumab (MK-3475) Versus Pembrolizumab Alone as Treatment in Participants With Mismatch Repair Proficient Endometrial Cancer (MK-2870-033/TroFuse-033/GOG-3119/ENGOT-en29)

Vključevanje udeležencevFaza 3
  • Houston Methodist Hospital ( Site 6057), Houston
Starost 18 in več · Ženske · Posodobljeno 17. sep. 2026 · NCT06952504

A Phase 1/2 Trial of TER-2013 in Patients With Solid Tumors Harboring AKT/PI3K/PTEN Pathway Alterations

Vključevanje udeležencevFaza 1/2
  • MD Anderson Cancer Center, Houston
Starost 18 in več · Vsi spoli · Posodobljeno 17. sep. 2026 · NCT07109726

Endometrial Cancer, Risk Factors and Prevention Strategies: Perspectives of Patients and At-Risk Women

Vključevanje udeležencevOpazovalna študija
  • MD Anderson Cancer Center, Houston
Starost 18 in več · Ženske · Posodobljeno 16. sep. 2026 · NCT06409052

Sentinel Node Biopsy in Endometrial Cancer

Vključevanje udeležencevFaza 3
  • Houston Methodist Hospital, Houston
Starost 18 in več · Ženske · Posodobljeno 15. sep. 2026 · NCT04073706

A Phase I/IIa Study of AZD8205 Given Alone or Combined, in Participants With Advanced/Metastatic Solid Malignancies

Vključevanje udeležencevFaza 1/2
  • Research Site, Houston
Starost 18 in več · Vsi spoli · Posodobljeno 11. sep. 2026 · NCT05123482

Open Label Study to Evaluate BL-M07D1 in HER2 Expressing Malignant Solid Tumors

Vključevanje udeležencevFaza 1
  • Oncology Consultants, Houston
Starost 18 in več · Vsi spoli · Posodobljeno 10. sep. 2026 · NCT06293898

A Study of Sofe-M in Participants With Selected Advanced Solid Tumors

Vključevanje udeležencevFaza 1
  • The University of Texas - MD Anderson Cancer Center, Houston
Starost 18 in več · Vsi spoli · Posodobljeno 4. sep. 2026 · NCT06400472

Phase 1 Study to Assess Safety, Tolerability, Pharmacokinetics, Immunogenicity, and Antitumor Activity of ARR-002 in Advanced or Metastatic Ovarian or Endometrial Cancer.

Vključevanje udeležencevFaza 1
  • MD Anderson Cancer Center, Houston
Starost 18 in več · Ženske · Posodobljeno 3. sep. 2026 · NCT07755436

DESTINY-Endometrial01: A Phase III Study of Trastuzumab Deruxtecan Plus Rilvegostomig or Pembrolizumab as First-Line Treatment of HER2-Expressing (IHC 3+/2+), Mismatch Repair Proficient (pMMR) Endometrial Cancer

Vključevanje udeležencevFaza 3
  • Research Site, Houston
Starost 18 in več · Ženske · Posodobljeno 3. sep. 2026 · NCT06989112

FT836 With or Without Chemotherapy and/or Monoclonal Antibodies, in Participants With Advanced Solid Tumors

Vključevanje udeležencevFaza 1
  • M. D. Anderson Cancer Center, Houston
Starost 18 in več · Vsi spoli · Posodobljeno 2. sep. 2026 · NCT07216105

Tegavivint for the Treatment of Recurrent or Refractory Solid Tumors, Including Lymphomas and Desmoid Tumors

Vključevanje udeležencevFaza 1/2
  • Baylor College of Medicine/Dan L Duncan Comprehensive Cancer Center, Houston
12 Months – 30 Years · Vsi spoli · Posodobljeno 25. avg. 2026 · NCT04851119

A Phase 1 Study of LNCB74 in Advanced Solid Tumors

Vključevanje udeležencevFaza 1
  • MD Anderson, Houston
Starost 18 in več · Vsi spoli · Posodobljeno 21. avg. 2026 · NCT06774963

Phase I/IIa Study of AZD5335 as Monotherapy and Combination Therapy in Participants With Solid Tumors

Vključevanje udeležencevFaza 1/2
  • Research Site, Houston
Starost 18–130 · Vsi spoli · Posodobljeno 21. avg. 2026 · NCT05797168

A Study to Test How Well Different Doses of BI 3820768 Are Tolerated by People With Advanced Cancer (Solid Tumours)

Vključevanje udeležencevFaza 1
  • The University of Texas MD Anderson Cancer Center, Houston
Starost 18 in več · Vsi spoli · Posodobljeno 21. avg. 2026 · NCT07306559

A Phase 2 Study of ACR-368 in Endometrial Adenocarcinoma

Vključevanje udeležencevFaza 2
  • University of Texas, MD Anderson Cancer Center, Houston
Starost 18 in več · Ženske · Posodobljeno 21. avg. 2026 · NCT05548296

A Phase 1 Study of NRM-823 in Participants With Locally Advanced or Metastatic Refractory Solid Tumors

Vključevanje udeležencevFaza 1
  • Normunity Investigational Site, Houston
Starost 18 in več · Vsi spoli · Posodobljeno 18. avg. 2026 · NCT07182149

FOG-001 in Locally Advanced or Metastatic Solid Tumors

Vključevanje udeležencevFaza 1/2
  • The University of Texas MD Anderson Cancer Center, Houston
Starost 18 in več · Vsi spoli · Posodobljeno 17. avg. 2026 · NCT05919264

Development of a Shared Decision Tool to Facilitate Uptake of the Levonorgestrel-releasing Intrauterine System for the Primary Prevention of Endometrial Cancer

Vključevanje udeležencevOpazovalna študija
  • The Harris Health System (LBJ), Houston
  • MD Anderson Cancer Center, Houston
Starost 18 in več · Ženske · Posodobljeno 12. avg. 2026 · NCT07382583

A Study of PHST001 in Advanced Solid Tumors

Vključevanje udeležencevFaza 1
  • MD Anderson Cancer Center, Houston
Starost 18 in več · Vsi spoli · Posodobljeno 12. avg. 2026 · NCT06840886

A Study of MGC026 in Participants With Advanced Solid Tumors

Vključevanje udeležencevFaza 1
  • The University of Texas MD Anderson Cancer Center, Houston
  • University of Texas Health Science Center at Houston, Houston
Starost 18 in več · Vsi spoli · Posodobljeno 11. avg. 2026 · NCT06242470

A Study of a Selective T Cell Receptor (TCR) Targeting, Bifunctional Antibody-fusion Molecule STAR0602 in Participants With Advanced Solid Tumors

Vključevanje udeležencevFaza 1/2
  • The University of Texas, MD Anderson Cancer Center, Houston
Starost 18 in več · Vsi spoli · Posodobljeno 11. avg. 2026 · NCT05592626

Observational Study of Women With Endometrial Cancer Who Receive the Standard Treatment for Their Disease

Vključevanje udeležencevOpazovalna študija
  • Houston Methodist Cancer Center (Data Collection Only), Houston
Starost 18 in več · Ženske · Posodobljeno 7. avg. 2026 · NCT04291612

A Study of DM002 in Patients With Advanced Solid Tumors

Vključevanje udeležencevFaza 1/2
  • The University of Texas, MD Anderson Cancer Center, Houston
Starost 18 in več · Vsi spoli · Posodobljeno 7. avg. 2026 · NCT06751329

Study Evaluating the Safety and Efficacy of HWK-007, a PTK7-directed Antibody Drug Conjugate in Participants With Advanced Solid Tumors

Vključevanje udeležencevFaza 1
  • NEXT - Oncology - Houston, Houston
Starost 18 in več · Vsi spoli · Posodobljeno 5. avg. 2026 · NCT07444814

Puxitatug Samrotecan (AZD8205) Monotherapy vs Chemotherapy in B7-H4-selected Endometrial Cancer (Bluestar-Endometrial01)

Vključevanje udeležencevFaza 3
  • Research Site, Houston
Starost 18 in več · Ženske · Posodobljeno 29. jul. 2026 · NCT07044336

Study of Orally Administered MOMA-341 in Participants With Advanced or Metastatic Solid Tumors

Vključevanje udeležencevFaza 1
  • Investigative Site #129, Houston
Starost 18 in več · Vsi spoli · Posodobljeno 23. jul. 2026 · NCT06974110

A Study of PF-08046054/SGN-PDL1V in Advanced Solid Tumors

Vključevanje udeležencevFaza 1
  • The University of Texas MD Anderson Cancer Center Investigational Pharmacy Services, Houston
  • The University of Texas MD Anderson Cancer Center, Houston
Starost 18 in več · Vsi spoli · Posodobljeno 22. jul. 2026 · NCT05208762

Study of RGT-490 in Patients With PIK3CA-Mutated Advanced Solid Tumors

Vključevanje udeležencevFaza 1
  • The University of Texas MD Anderson Cancer Center, Houston
  • NEXT Houston, Houston
Starost 18 in več · Vsi spoli · Posodobljeno 22. jul. 2026 · NCT07524322

Phase I Study of Tumor Treating Fields (TTF) in Combination With Cabozantinib or With Pembrolizumab and Nab-Paclitaxel in Patients With Advanced Solid Tumors Involving the Abdomen or Thorax

Vključevanje udeležencevFaza 1
  • M D Anderson Cancer Center, Houston
Starost 18 in več · Vsi spoli · Posodobljeno 16. jul. 2026 · NCT05092373

A Phase 2 Study of Zanidatamab in Patients With HER2-expressing Tumors

Vključevanje udeležencevFaza 2
  • MD Anderson Cancer Center, Houston
Starost 18 in več · Vsi spoli · Posodobljeno 10. jul. 2026 · NCT06695845

First-in-Human Study of Tersolisib (STX-478) as Monotherapy and in Combination With Other Antineoplastic Agents in Participants With Advanced Solid Tumors

Vključevanje udeležencevFaza 1/2
  • University of Texas MD Anderson Cancer Center, Houston
Starost 18 in več · Vsi spoli · Posodobljeno 7. jul. 2026 · NCT05768139

A Phase 1 Dose-escalation Trial of KST-6051 in Participants With Advanced Solid Tumors With Kirsten Rat Sarcoma Viral Oncogene Homolog (KRAS) Mutation

Vključevanje udeležencevFaza 1
  • The University of Texas MD Anderson Cancer Center, Houston
Starost 18 in več · Vsi spoli · Posodobljeno 29. jun. 2026 · NCT07458347

A Study of Emiltatug Ledadotin (Emi-Le) in Participants With Solid Tumors

Vključevanje udeležencevFaza 1/2
  • MD Anderson, Houston
Starost 18 in več · Vsi spoli · Posodobljeno 29. jun. 2026 · NCT05377996

Phase 1/2 Study of ETX-636 in Participants With Advanced Solid Tumors

Vključevanje udeležencevFaza 1/2
  • The University of Texas MD Anderson Cancer Center, Houston
Starost 18 in več · Vsi spoli · Posodobljeno 23. jun. 2026 · NCT06993844

A Study of LY4175408 in Participants With Advanced Cancer

Vključevanje udeležencevFaza 1
  • MD Anderson Cancer Center, Houston
Starost 18 in več · Vsi spoli · Posodobljeno 23. jun. 2026 · NCT07046923

A Study of IDE034 in Adult Participants With Locally Advanced/Metastatic Solid Tumors Types

Vključevanje udeležencevFaza 1
  • MD Anderson, Houston
  • NEXT Texas LLC - Houston, Houston
Starost 18 in več · Vsi spoli · Posodobljeno 18. jun. 2026 · NCT07503808

Phase I Trial Testing the Safety and Tolerability of Chemoradiation Followed by Chemotherapy + Dostarlimab for Stage IIIC, Node Positive, Endometrial Cancer

Vključevanje udeležencevFaza 1
  • M D Anderson Cancer Center, Houston
Starost 18 in več · Ženske · Posodobljeno 8. jun. 2026 · NCT05819892

A Phase 1/1B Study of ST-01156, a Small Molecule RBM39 Degrader, in Patients With Advanced Solid Malignancies

Vključevanje udeležencevFaza 1
  • The University of Texas MD Anderson Cancer Center, Houston
Starost 16 in več · Vsi spoli · Posodobljeno 2. jun. 2026 · NCT07197554

A Study of Lorigerlimab in Participants With Advanced Solid Tumors

Vključevanje udeležencevFaza 2
  • The University of Texas MD Anderson Cancer Center, Gynecologic Oncology Center, Houston
Starost 18 in več · Ženske · Posodobljeno 2. jun. 2026 · NCT06730347

IACS-6274 With or Without Bevacizumab and Paclitaxel for the Treatment of Advanced Solid Tumors

Vključevanje udeležencevFaza 1
  • M D Anderson Cancer Center, Houston
Starost 18 in več · Vsi spoli · Posodobljeno 1. jun. 2026 · NCT05039801

Dose Escalation and Dose Expansion Study of MDX2001 in Patients With Advanced Solid Tumors

Vključevanje udeležencevFaza 1/2
  • MD Anderson Cancer Center, Houston
Starost 18 in več · Vsi spoli · Posodobljeno 6. maj 2026 · NCT06239194

A Study of PARG Inhibitor ETX-19477 in Patients With Advanced Solid Malignancies

Vključevanje udeležencevFaza 1/2
  • MD Anderson Cancer Center, Houston
Starost 18 in več · Vsi spoli · Posodobljeno 27. mar. 2026 · NCT06395519

Talazoparib and Radiation Therapy in Treating Patients With Locally Recurrent Gynecologic Cancers

Vključevanje udeležencevFaza 1
  • M D Anderson Cancer Center, Houston
Starost 18 in več · Vsi spoli · Posodobljeno 11. mar. 2026 · NCT03968406

A Study of MT-4561 in Patients With Various Advanced Solid Tumors

Vključevanje udeležencevFaza 1/2
  • The University of Texas MD Anderson Cancer Center, Houston
Starost 18 in več · Vsi spoli · Posodobljeno 11. dec. 2025 · NCT06943521

A Phase I/II Study of VLS-1488 in Subjects With Advanced Cancer

Vključevanje udeležencevFaza 1/2
  • M.D. Anderson Cancer Center, Houston
Starost 18 in več · Vsi spoli · Posodobljeno 4. nov. 2025 · NCT05902988

A Study of Lifileucel (Tumor-infiltrating Lymphocytes) in Adults With Advanced Endometrial Cancer.

Vključevanje udeležencevFaza 2
  • MD Anderson Cancer Center - U of Texas, Houston
Starost 18–70 · Ženske · Posodobljeno 30. okt. 2025 · NCT06481592

SYNERGY-AI: Artificial Intelligence Based Precision Oncology Clinical Trial Matching and Registry

Vključevanje udeležencevOpazovalna študija
  • Massive Bio SYNERGY-AI site, Houston
Vse starosti · Vsi spoli · Posodobljeno 28. okt. 2025 · NCT03452774

Uterine Manipulation During Minimally Invasive Surgery for Early Stage Endometrial Cancer

Vključevanje udeležencev
  • Baylor College of Medicine- McNair Campus, Houston
  • Baylor College of Medicine, Houston
  • Ben Taub General Hospital, Houston
  • in še 1
Starost 18–90 · Ženske · Posodobljeno 15. okt. 2025 · NCT04586959

A Study to Evaluate TROP2 ADC LCB84 Single Agent and in Combination With an Anti-PD-1 Ab in Advanced Solid Tumors

Vključevanje udeležencevFaza 1/2
  • MD Anderson Cancer Center, Houston
Starost 18 in več · Vsi spoli · Posodobljeno 24. sep. 2025 · NCT05941507

BP1001-A in Patients With Advanced or Recurrent Solid Tumors

Vključevanje udeležencevFaza 1
  • The University of Texas M.D. Anderson Cancer Center, Houston
Starost 18 in več · Vsi spoli · Posodobljeno 7. mar. 2025 · NCT04196257

A Study of GV20-0251 Monotherapy and GV20-0251 in Combination With Pembrolizumab in Participants With Solid Tumor Malignancies

Vključevanje udeležencevFaza 1/2
  • Oncology Consultants, P.A., Houston
  • The University of Texas M. D. Anderson Cancer Center, Houston
Starost 18 in več · Vsi spoli · Posodobljeno 13. feb. 2025 · NCT05669430

Comprehensive Outcomes for After Cancer Health

Vključevanje udeležencevVabljeni zdravi prostovoljci
  • The University of Texas MD Anderson Cancer Center, Houston
  • UT Health Houston, Houston
Starost 18 in več · Vsi spoli · Posodobljeno 11. dec. 2024 · NCT05349227

HPV Vaccine, Imiquimod, and Metformin Combination Trial

Vključevanje udeležencevFaza 2
  • Baylor St. Luke's Medical Center- Dan L. Duncan Comprehensive Cancer Center, Houston
  • Harris Health Smith Clinic, Houston
Starost 18–64 · Ženske · Posodobljeno 13. nov. 2024 · NCT06686043

Študije za Rak endometrija v drugih mestih

Druge študije v Houston

Vir: ClinicalTrials.gov, podatki pridobljeni 5. okt. 2026. Vsaka študija ima svoje pogoje vključitve; ekipa študije odloči, kdo lahko sodeluje.